Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,558,423
+$2,523,461 QoQ
Shares Held
10,167
+6633.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,762
of 4,153 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New Age Alpha Advisors, LLC holds $68,343,591 across 9 Drug Manufacturers - General names. ABBV ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
122,881 | $15,790,208 | |
| 2 | AMGN |
Amgen Inc
|
43,405 | $15,717,818 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
88,072 | $11,127,016 | |
| 4 | LLY |
ELI LILLY & Co
|
8,257 | $9,903,694 | |
| 5 | JNJ |
Johnson & Johnson
|
34,467 | $8,753,583 | |
| 6 | PFE |
Pfizer Inc
|
117,185 | $2,821,814 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
10,167 | $2,558,423 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24,805 | $1,429,264 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,558,423 | 10,167 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $34,962 | 151 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $28,028 | 151 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $31,637 | 151 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $23,634 | 133 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $16,193 | 82 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||